My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.

    Smith MF Jr, Hiepe F, Dörner T, Burmester G.

    Arthritis Res Ther. 2009;11(6):255. Epub 2009 Nov 19.PMID: 19939293 [PubMed - in process]Related articles

    2.

    [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]

    Ampélas JF, Wattiaux MJ, Van Amerongen AP.

    Encephale. 2001 Nov-Dec;27(6):588-99. French. PMID: 11865567 [PubMed - indexed for MEDLINE]Related articles

    3.

    The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.

    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria.

    Arthritis Rheum. 2004 Nov;50(11):3418-26.PMID: 15529383 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The applications of biomarkers in early clinical drug development to improve decision-making processes.

    Kuhlmann J, Wensing G.

    Curr Clin Pharmacol. 2006 May;1(2):185-91. Review.PMID: 18666370 [PubMed - indexed for MEDLINE]Related articles

    5.

    ECNP consensus meeting. Bipolar depression. Nice, March 2007.

    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

    Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. Epub 2008 May 23. Review.PMID: 18501566 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical trial design in systemic lupus erythematosus: lessons learned and future directions.

    Strand V.

    Lupus. 2004;13(5):406-11. Review.PMID: 15230300 [PubMed - indexed for MEDLINE]Related articles

    7.

    Biomarkers for systemic lupus erythematosus: a review and perspective.

    Liu CC, Manzi S, Ahearn JM.

    Curr Opin Rheumatol. 2005 Sep;17(5):543-9. Review.PMID: 16093831 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

    Van Vaerenbergh K.

    Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

    10.

    Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.

    FitzGerald JD, Grossman JM.

    Lupus. 1999;8(8):638-44.PMID: 10568901 [PubMed - indexed for MEDLINE]Related articles

    11.

    Outcome measures to be used in clinical trials in systemic lupus erythematosus.

    Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.

    J Rheumatol. 1999 Feb;26(2):490-7.PMID: 9972993 [PubMed - indexed for MEDLINE]Related articles

    12.

    Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

    Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774. PMID: 12869717 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A refined symptom-based approach to diagnose pulmonary tuberculosis in children.

    Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N.

    Pediatrics. 2006 Nov;118(5):e1350-9.PMID: 17079536 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    B-cell-targeted therapy for systemic lupus erythematosus.

    Sabahi R, Anolik JH.

    Drugs. 2006;66(15):1933-48.PMID: 17100405 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

    Encephale. 2005 Mar-Apr;31(2):235-46. Review. French. PMID: 15959450 [PubMed - indexed for MEDLINE]Related articles

    16.

    Biomarkers in aquatic plants: selection and utility.

    Brain RA, Cedergreen N.

    Rev Environ Contam Toxicol. 2009;198:49-109. Review.PMID: 19253039 [PubMed - indexed for MEDLINE]Related articles

    17.

    Update on emerging drug therapies for systemic lupus erythematosus.

    Mok CC.

    Expert Opin Emerg Drugs. 2010 Mar;15(1):53-70.PMID: 20148712 [PubMed - in process]Related articles

    18.

    Molecular biological assessment methods and understanding the course of the HIV infection.

    Katzenstein TL.

    APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alternative strategies in drug development: clinical pharmacological aspects.

    Kuhlmann J.

    Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Review.PMID: 10599949 [PubMed - indexed for MEDLINE]Related articles

    20.

    NIH Consensus Statement on Management of Hepatitis C: 2002.

    [No authors listed]

    NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. Review.PMID: 14768714 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk